Kiran Vij

2025

HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma

Yamamoto, N., Dobersch, S., Loveless, I., Samraj, A. N., Jang, G. H., Haraguchi, M., Kang, L. I., Ruzinova, M. B., Vij, K. R., Mudd, J. L., Walsh, T., Safyan, R. A., Chiorean, E. G., Hingorani, S. R., Bolton, N. M., Li, L., Fields, R. C., DeNardo, D. G., Notta, F. & Crawford, H. C. & 2 others, Steele, N. G. & Kugel, S., Feb 15 2025, In: Clinical Cancer Research. 31, 4, p. 733-745 13 p.

Research output: Contribution to journal › Article › peer-review

Severe acute cutaneous-only graft-versus-host disease after late relapse of chronic myeloid leukemia and ultraviolet B phototherapy

Beeler, J. S., Peravali, R., Augustin, K. M., Musiek, A. C. M., Vij, K., Patel, D. A. & DiPersio, J. F., Mar 2025, In: Haematologica. 110, 3, p. 804-807 4 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2024

Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager

Eissenberg, L. G., Ritchey, J. K., Rettig, M. P., Patel, D. A., Vij, K., Gao, F., Smith, V., Han, T. H. & DiPersio, J. F., May 2024, In: PloS one. 19, 5 MAY, e0300174.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

Endocrine-Sensitive Disease Rate in Postmenopausal Patients with Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial

Ma, C. X., Suman, V. J., Sanati, S., Vij, K., Anurag, M., Leitch, A. M., Unzeitig, G. W., Hoog, J., Fernandez-Martinez, A., Fan, C., Gibbs, R. A., Watson, M. A., Dockter, T. J., Hahn, O., Guenther, J. M., Caudle, A., Crouch, E., Tiersten, A., Mita, M. & Razaq, W. & 10 others, Hieken, T. J., Wang, Y., Rimawi, M. F., Weiss, A., Winer, E. P., Hunt, K. K., Perou, C. M., Ellis, M. J., Partridge, A. H. & Carey, L. A., Mar 21 2024, In: JAMA oncology. 10, 3, p. 362-371 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Abro, B., Maurer, M. J., Habermann, T. M., Burack, W. R., Chapman, J. R., Cohen, J. B., Friedberg, J. W., Inghirami, G., Kahl, B. S., Larson, M. C., Link, B. K., Lossos, I. S., Martin, P., McDonnell, T. J., Nastoupil, L. J., Riska, S. M., Syrbu, S., Vega, F., Vij, K. R. & Flowers, C. R. & 3 others, Cerhan, J. R., Jaye, D. L. & Feldman, A. L., Nov 7 2024, In: Blood. 144, 19, p. 2063-2066 4 p.

Research output: Contribution to journal › Article › peer-review

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes

Cerhan, J. R., Maurer, M. J., Link, B. K., Feldman, A. L., Habermann, T. M., Jaye, D. L., Burack, W. R., McDonnell, T. J., Vega, F., Chapman, J. R., Syrbu, S., Vij, K. R., Inghirami, G., Leonard, J. P., Bernal-Mizrachi, L., Farooq, U., Witzig, T. E., Weiner, G. J., Wang, Y. & Alderuccio, J. P. & 23 others, Slager, S. L., Larson, M. C., Riska, S. M., Gysbers, B. J., Lunde, J. J., Reicks, T. W., Ayers, A. A., O'Leary, C. B., Yost, K. J., Liu, H., Nowakowski, G. S., Ruan, J., Chihara, D., Koff, J. L., Casulo, C., Thompson, C. A., Cohen, J. B., Kahl, B. S., Nastoupil, L. J., Lossos, I. S., Friedberg, J. W., Martin, P. & Flowers, C. R., Mar 2024, In: American journal of hematology. 99, 3, p. 408-421 14 p.

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

2023

Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting An Expert Panel Consensus

Gru, A. A., Lim, M. S., Dogan, A., Horwitz, S. M., Delabie, J., Fu, K., Peker, D., Reddy, V. V. B., Xu, M. L., Vij, K., Slack, G. W., Miranda, R. N., Jagadeesh, D., Lisano, J. M., Hsi, E. D. & Torlakovic, E., Jan 2023, In: Archives of Pathology and Laboratory Medicine. 147, 1, p. 79-86 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations

Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity

Liu, X., Hogg, G. D., Zuo, C., Borcherding, N. C., Baer, J. M., Lander, V. E., Kang, L. I., Knolhoff, B. L., Ahmad, F., Osterhout, R. E., Galkin, A. V., Bruey, J. M., Carter, L. L., Mpoy, C., Vij, K. R., Fields, R. C., Schwarz, J. K., Park, H., Gupta, V. & DeNardo, D. G., Jun 12 2023, In: Cancer Cell. 41, 6, p. 1073-1090.e12

Research output: Contribution to journal › Article › peer-review

Open Access

40 Scopus citations

Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma

Barnell, E. K., Skidmore, Z. L., Newcomer, K. F., Chavez, M., Campbell, K. M., Cotto, K. C., Spies, N. C., Ruzinova, M. B., Wang, T., Abro, B., Kreisel, F., Parikh, B. A., Duncavage, E. J., Frater, J. L., Lee, Y. S., Hassan, A., King, J. A., Kohnen, D. R., Fiala, M. A. & Welch, J. & 6 others, Uy, G. L., Vij, K., Vij, R., Griffith, M., Griffith, O. L. & Wartman, L. D., Jan 24 2023, In: Blood Advances. 7, 2, p. 236-245 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

11 Scopus citations

S100A9 upregulated by IFNGR signaling blockade functions as a novel GVHD suppressor without compromising GVL in mice

Kim, S., Lim, S., Kim, B., Ritchey, J., Vij, K., Prior, J., Marsala, L., Stoner, A., Gao, F., Achilefu, S., Cooper, M. L., DiPersio, J. F. & Choi, J., Feb 23 2023, In: Blood. 141, 8, p. 945-950 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

2022

Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR

Kim, S., Ashami, K., Lim, S., Staser, K., Vij, K., Santhanam, S., Ritchey, J., Peterson, S., Gao, F., Ciorba, M. A., Cooper, M. L., DiPersio, J. F. & Choi, J., Jan 2022, In: Leukemia. 36, 1, p. 292-295 4 p.

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

NIH SenNet Consortium to map senescent cells throughout the human lifespan to understand physiological health

Stanford TDA, University of Connecticut TMC, University of Michigan TDA, University of Minnesota TMC, University of Pittsburgh TMC, University of Washington TDA, Washington University TMC, Yale TMC, SenNet Consortium, Writing Group, Brown University TDA, Buck Institute for Research on Aging TMC/TDA, Consortium Organization and Data Coordinating Center (CODCC), Columbia TMC, Duke University TMC, Massachusetts General Hospital TDA, Mayo Clinic TDA & National Institute of Health (NIH), Dec 2022, In: Nature Aging. 2, 12, p. 1090-1100 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

62 Scopus citations

2021

Phospho-ser⁷⁸⁴-vcp drives resistance of pancreatic ductal adenocarcinoma to genotoxic chemotherapies and predicts the chemo-sensitizing effect of vcp inhibitor

Wang, F., Vij, K., Li, L., Dodhiawala, P., Lim, K. H. & Shao, J., Oct 1 2021, In: Cancers. 13, 20, 5076.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

2020

Phospho-Ser⁷⁸⁴-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer

Zhu, C., Rogers, A., Asleh, K., Won, J., Gao, D., Leung, S., Li, S., Vij, K. R., Zhu, J., Held, J. M., You, Z., Nielsen, T. O. & Shao, J., Jun 9 2020, In: Cell Reports. 31, 10, 107745.

Research output: Contribution to journal › Article › peer-review

Open Access

23 Scopus citations

Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis

Xu, M. L., Gabali, A., Hsi, E. D., Fedoriw, Y., Vij, K., Salama, M. E., Ramchandren, R., O'Malley, D., Wick, M. R., Battistella, M. & Gru, A. A., Feb 1 2020, In: American Journal of Surgical Pathology. 44, 2, p. E1-E14

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

2019

Reactivity with the EpCAM-specific antibodies MOC-31 and Ber-Ep4 in plasma cell neoplasms: a potential diagnostic pitfall in cytology samples

Weimholt, R. C., Sharifai, N., Abro, B., Vij, K. & Bernadt, C., Sep 1 2019, In: Journal of the American Society of Cytopathology. 8, 5, p. 265-269 5 p.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib

Goldsmith, S. R., Ur Rehman, S. S., Shirai, C. L., Vij, K. & DiPersio, J. F., Dec 10 2019, In: Blood Advances. 3, 23, p. 4131-4135 5 p.

Research output: Contribution to journal › Article › peer-review

Open Access

39 Scopus citations

2018

Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease

Choi, J., Cooper, M. L., Staser, K., Ashami, K., Vij, K. R., Wang, B., Marsala, L., Niswonger, J., Ritchey, J., Alahmari, B., Achilefu, S., Tsunoda, I., Schroeder, M. A. & DiPersio, J. F., Nov 1 2018, In: Leukemia. 32, 11, p. 2483-2494 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

79 Scopus citations

2017

A phase II trial of neoadjuvant MK-2206, an AKT inhibitor, with anastrozole in clinical stage II or III PIK3CA-mutant ER-positive and HER2-negative breast cancer

Ma, C. X., Suman, V., Goetz, M. P., Northfelt, D., Burkard, M. E., Ademuyiwa, F., Naughton, M., Margenthaler, J., Aft, R., Gray, R., Tevaarwerk, A., Wilke, L., Haddad, T., Moynihan, T., Loprinzi, C., Hieken, T., Barnell, E. K., Skidmore, Z. L., Feng, Y. Y. & Krysiak, K. & 14 others, Hoog, J., Guo, Z., Nehring, L., Wisinski, K. B., Mardis, E., Hagemann, I. S., Vij, K., Sanati, S., Al-Kateb, H., Griffith, O. L., Griffith, M., Doyle, L., Erlichman, C. & Ellis, M. J., Nov 15 2017, In: Clinical Cancer Research. 23, 22, p. 6823-6832 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

67 Scopus citations

Azacitidine mitigates graft-versus-host disease via differential effects on the proliferation of T effectors and natural regulatory T cells in vivo

Cooper, M. L., Choi, J., Karpova, D., Vij, K., Ritchey, J., Schroeder, M. A. & DiPersio, J. F., May 1 2017, In: Journal of Immunology. 198, 9, p. 3746-3754 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

35 Scopus citations

HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice

Esser, A. K., Rauch, D. A., Xiang, J., Harding, J. C., Kohart, N. A., Ross, M. H., Su, X., Wu, K., Huey, D., Xu, Y., Vij, K., Green, P. L., Rosol, T. J., Niewiesk, S., Ratner, L. & Weilbaecher, K. N., 2017, In: Oncotarget. 8, 41, p. 69250-69263 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

15 Scopus citations

NeoPalAna: Neoadjuvant palbociclib, a cyclin-dependent kinase 4/6 inhibitor, and anastrozole for clinical stage 2 or 3 estrogen receptor–positive breast cancer

Ma, C. X., Gao, F., Luo, J., Northfelt, D. W., Goetz, M., Forero, A., Hoog, J., Naughton, M., Ademuyiwa, F., Suresh, R., Anderson, K. S., Margenthaler, J., Aft, R., Hobday, T., Moynihan, T., Gillanders, W., Cyr, A., Eberlein, T. J., Hieken, T. & Krontiras, H. & 14 others, Guo, Z., Lee, M. V., Spies, N. C., Skidmore, Z. L., Griffith, O. L., Griffith, M., Thomas, S., Bumb, C., Vij, K., Huang Bartlett, C., Koehler, M., Al-Kateb, H., Sanati, S. & Ellis, M. J., Aug 1 2017, In: Clinical Cancer Research. 23, 15, p. 4055-4065 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

270 Scopus citations

Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib

Bagegni, N., Thomas, S., Liu, N., Luo, J., Hoog, J., Northfelt, D. W., Goetz, M. P., Forero, A., Bergqvist, M., Karen, J., Neumüller, M., Suh, E. M., Guo, Z., Vij, K., Sanati, S., Ellis, M. & Ma, C. X., Nov 21 2017, In: Breast Cancer Research. 19, 1, 123.

Research output: Contribution to journal › Article › peer-review

Open Access

63 Scopus citations

2008

Aberrant expression of α-fetoprotein in intrahepatic cholangiocarcinoma: An exceptional occurrence

Vij, K. & Wang, H. L., Apr 2008, In: International Journal of Surgical Pathology. 16, 2, p. 194-198 5 p.

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

2004

Mice expressing a dominant-negative Ret mutation phenocopy human Hirschsprung disease and delineate a direct role of Ret in spermatogenesis

Jain, S., Naughton, C. K., Yang, M., Strickland, A., Vij, K., Encinas, M., Golden, J., Gupta, A., Heuckeroth, R., Johnson, E. M. & Milbrandt, J., Nov 2004, In: Development. 131, 21, p. 5503-5513 11 p.

Research output: Contribution to journal › Article › peer-review

115 Scopus citations

Kiran Vij

Research output

Search results